← All stories
Markets
Is Hikma Pharmaceuticals Stock Set To Extend Its Post-Results Rally?
Highlights First-half revenue and profit measures advanced on the prior year across the generics and branded portfolio Management reiterated full-year guidance for group revenue and operating profit ranges Some analysts trimmed longer-term…
Covered by 1 outlet
All coverage · 1 article